证券代码：301487 证券简称：盟固利 公告编号：2026-008 天津国安盟固利新材料科技股份有限公司 关于前期会计差错更正及追溯调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示：天津国安盟固利新材料科技股份有限公司（以下简称"公 司"）本次对前期会计差错更正，不会导致公司已披露的相关年报出现盈亏性 质的改变。 一、前期差错更正事项概述 2025 年 12 月 31 日，公司收到中国证券监督管理委员会天津监管局（以下 简称"天津证监局"）《关于对天津国安盟固利新材料科技股份有限公司采取 责令改正并对钱建林、朱武、周国水采取监管谈话措施的决定》（津证监措施 [2025]44 号）（以下简称"决定书"）。决定书指出：公司 2023 年三季报、 2023 年年报、2024 年年报、2025 年一季报存在会计差错，其中，公司 2023 年 三季报、年报收入均多计 4,380.53 万元，净利润均多计 112.83 万元，2024 年 年报和 2025 年一季报净利润分别少计 36.48 万元、62.43 万元；2025 年半年报 存在会计差 ...

天津国安盟固利新材料科技股份有限公司 关于前期会计差错更正后的财务报表及相关附注 天津国安盟固利新材料科技股份有限公司（以下简称"公司"）于2026年1月 21日召开了第四届董事会第十七次会议，审议通过了《关于前期会计差错更正及追 溯调整的议案》。公司根据《公开发行证券的公司信息披露编报规则第19号——财 务信息的更正及相关披露》以及《企业会计准则第28号——会计政策、会计估计变 更和差错更正》等相关规定，对2023年第三季度、2023年、2024年、2025年第一季 度、2025年半年度、2025年第三季度财务报表及相关附注进行更正。（除特殊注明 外，单位均为人民币元，粗体字为本次差错更正影响数据） 更正后的财务报表及相关附注具体情况如下： 2、合并利润表 | 项目 | 本期金额 | 上期金额 | | --- | --- | --- | | 一、营业总收入 | 1,730,647,355.48 | 2,560,491,633.42 | | 其中：营业收入 | 1,730,647,355.48 | 2,560,491,633.42 | | 利息收入 | | | | 已赚保费 | | | | 手续费及佣金收入 ...

第二章 财务管理组织结构 天津国安盟固利新材料科技股份有限公司 财务会计制度 第一章 总则 第一条 为规范天津国安盟固利新材料科技股份有限公司及其控股子公司的 财务会计行为，有效落实国家会计法律法规，统一公司会计核算标准，保证会计 信息质量真实、完整，根据《中华人民共和国公司法》《中华人民共和国会计法》 《企业会计准则》《会计基础工作规范》及相关法律法规，结合公司实际情况， 制定本制度。 第二条 本制度适用于天津国安盟固利新材料科技股份有限公司及纳入合并 财务报表范围的各级子公司（以下统称"公司"）。 第四条 财务部按照国家相关法规制定公司会计政策及各项制度，组织公司 会计核算及财务管理工作，编制各期财务报表和年度财务报告，配合外部审计机 构完成年度审计工作。 非同一控制下企业合并：合并成本为购买方在购买日为取得被购买方的控制 权而付出的资产、发生或承担的负债以及发行的权益性证券的公允价值。合并成 本大于合并中取得的被购买方可辨认净资产公允价值份额的差额，确认为商誉； 合并成本小于合并中取得的被购买方可辨认净资产公允价值份额的差额，计入当 期损益。在合并中取得的被购买方符合确认条件的各项可辨认资产、负债及或有 ...

（一）审议通过《关于前期会计差错更正及追溯调整的议案》 证券代码：301487 证券简称：盟固利 公告编号：2026-007 天津国安盟固利新材料科技股份有限公司 第四届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 天津国安盟固利新材料科技股份有限公司（以下简称"公司"）第四届董 事会第十七次会议通知于 2026 年 1 月 19 日以通讯方式送达全体董事。本次会 议于 2026 年 1 月 21 日以现场及通讯方式在公司会议室召开，本次会议应到董 事 9 人，实际出席会议董事 9 人。会议由董事长钱建林先生主持，会议的召集、 召开和表决程序符合《公司法》和《公司章程》的有关规定，会议合法有效。 二、董事会会议审议情况 董事会认为，公司本次会计差错更正及追溯调整符合《企业会计准则第 28 号——会计政策、会计估计变更和差错更正》和《公开发行证券的公司信息披 露编报规则第 19 号——财务信息的更正及相关披露》等相关规定，更正后的财 务数据及财务报表能够更加客观、准确地反映公司财务状况及经营成果。公司 关于本 ...

关于天津国安盟固利新材料科技 股份有限公司 前期会计差错更正专项说明的鉴 证报告 关于天津国安盟固利新材料科技股份有限公司 前期会计差错更正专项说明的鉴证报告 信会师报字[2026]第 ZA10053 号 天津国安盟固利新材料科技股份有限公司全体股东： 我们接受委托，对后附的天津国安盟固利新材料科技股份有限公 司（以下简称"盟固利公司"）2023 年度、2024 年度前期会计差错更 正专项说明（以下简称"专项说明"）执行了合理保证的鉴证业务。 一、管理层的责任 盟固利公司管理层的责任是按照《企业会计准则第 28 号——会 计政策、会计估计变更和差错更正》、中国证券监督管理委员会《公 开发行证券的公司信息披露编报规则第 19 号——财务信息的更正及 相关披露》、《深圳证券交易所创业板股票上市规则》及《深圳证券交 易所创业板上市公司自律监管指南第 1 号——业务办理》的相关规定 编制专项说明，并确保专项说明真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是在执行鉴证工作的基础上对专项说明发表鉴证结 论。 四、鉴证结论 我们认为，盟固利公司 2023 年度、2024 年度 ...

Core Viewpoint - The company has acknowledged a financial accounting oversight leading to administrative regulatory measures from the Tianjin Securities Regulatory Bureau, clarifying that there is no financial fraud involved [1] Group 1 - The company received an administrative regulatory decision from the Tianjin Securities Regulatory Bureau on December 31, 2025 [1] - The issue was caused by a lapse in financial accounting processes, not by fraudulent activities [1] - The company has initiated corrective actions and is enhancing its financial internal control system to ensure the accuracy and completeness of financial information [1] Group 2 - The current situation does not trigger any delisting or risk warning scenarios as per relevant regulations [1]

Group 1 - The company, Mengguli (301487.SZ), has stated on its interactive platform that it is not currently involved in the nuclear battery business [1]

Group 1 - Xianghe Industrial signed a contract worth 43.1041 million yuan with China Railway 15th Bureau, accounting for approximately 6.5% of the company's projected revenue for 2024 [1] - Dayu Water-saving's subsidiary won a bid for a project valued at 133 million yuan, with a construction period of 545 days [2] - China National Materials International's subsidiary signed a contract worth 299 million Canadian dollars for engineering design and procurement services [3] Group 2 - Baoland expects a net loss of approximately 75 million yuan for 2025, compared to a loss of 58.7224 million yuan in the previous year [4] - Changhong High-tech received an administrative regulatory decision due to inadequate internal controls and improper revenue recognition [5] - Debon Stock will be suspended from trading on January 21, 2026, pending a decision on its delisting [6] Group 3 - Haitai Technology anticipates a net profit increase of 226.86% to 323.97% for 2025, with an expected profit of 51.5 million to 66.8 million yuan [7] - Fushun Special Steel expects a net loss of 770 million to 870 million yuan for 2025, compared to a profit of 112 million yuan in the previous year [8] - Rejing Bio forecasts a net loss of 210 million to 230 million yuan for 2025, compared to a loss of 191 million yuan in the previous year [10] Group 4 - Sanyou Chemical expects a net profit of approximately 91 million yuan for 2025, a decrease of about 82% compared to the previous year [11] - Lianhuan Pharmaceutical received approval for clinical trials of a new drug for benign prostatic hyperplasia [12] - Samsung New Materials anticipates a net loss for 2025, indicating a decline in operational performance [13] Group 5 - Jinggong Technology expects a net profit increase of 36.1% to 70.13% for 2025, with an estimated profit of 200 million to 250 million yuan [14] - Zhongsheng Pharmaceutical's subsidiary signed a licensing agreement for the production and commercialization of RAY1225 injection, with total payments expected to reach 1 billion yuan [15] - Hengshuai shares saw a reduction of 600,000 convertible bonds held by its controlling shareholder [16] Group 6 - Buchang Pharmaceutical plans to repurchase shares worth 60 million to 120 million yuan for employee stock ownership plans [17] - Baike Bio expects a net loss of 220 million to 280 million yuan for 2025, marking a shift from profit to loss [18] - Weishi Electronics anticipates a net profit decrease of 53.27% to 61.61% for 2025, with expected profits of 21.49 million to 26.16 million yuan [19] Group 7 - China Automotive Research expects a net profit increase of 17.85% for 2025, with a projected profit of 1.06 billion yuan [20] - Hualan Biological's controlling shareholder raised the upper limit of its shareholding plan to 86.66 yuan per share [22] - Nasda anticipates a net loss for 2025, indicating a decline in financial performance [23] Group 8 - Haizheng Pharmaceutical received a warning letter from the Zhejiang Securities Regulatory Commission for financial data inaccuracies [24] - Mengguli received an administrative regulatory decision for accounting errors in its financial reports [25] - Zhongguancun's subsidiary received acceptance for a drug application for a heart-related treatment [26] Group 9 - Hosheng Silicon Industry was ordered to correct information disclosure violations by the Zhejiang Securities Regulatory Commission [27] - Meiteng Technology expects a net profit decrease of 22.4551 million to 28.5285 million yuan for 2025, a reduction of 55.21% to 70.14% [28] - Sanwei Co. received a warning letter for financial irregularities related to related party transactions [29] Group 10 - Ganyue Expressway expects a net profit increase of 3.18% for 2025, with a projected profit of 1.32 billion yuan [30] - Xinhang New Materials plans to acquire 51% of Hairete for 12.8826 million yuan [31] - China Software anticipates a net loss of 41 million to 49 million yuan for 2025, an improvement from the previous year's loss [32] Group 11 - Rongsheng Development expects a net loss for 2025, with losses not exceeding the previous year's audited net assets [33] - Northern Rare Earth anticipates a net profit increase of 117% to 135% for 2025, with expected profits of 2.176 billion to 2.356 billion yuan [34] - Energy-saving Wind Power received renewable energy subsidies totaling 1.507 billion yuan, a 122.74% increase from the previous year [35] Group 12 - Dongzhu Ecology expects a net loss of 935 million to 1.135 billion yuan for 2025, compared to a loss of 630 million yuan in the previous year [36] - Jingneng Real Estate anticipates a net loss of 986 million to 1.315 billion yuan for 2025, compared to a loss of 109 million yuan in the previous year [37] - Hailu Heavy Industry signed new orders worth 1.941 billion yuan for 2025, with total orders on hand amounting to 3.597 billion yuan [38] Group 13 - Dalian Thermal Power expects a net loss of 92 million to 112 million yuan for 2025, compared to a loss of 146 million yuan in the previous year [39] - Jiangsu Sop expects a net profit decrease of 52.99% to 62.4% for 2025, with profits projected between 8 million to 10 million yuan [40] - Lian Technology plans to initiate preparations for issuing H-shares and listing on the Hong Kong Stock Exchange [42] Group 14 - Zhenyang Development expects a net profit decrease of 58.13% to 64.94% for 2025, with profits projected between 67 million to 80 million yuan [43] - Sheneng Co. reported a 1.7% decrease in power generation for 2025, with total generation of 57.654 billion kWh [44] - XGIMI Technology's subsidiary received a development notification from a well-known domestic automotive manufacturer [45] Group 15 - Wanhua Chemical's MDI Phase II facility resumed production after maintenance [46] - Daqing Energy expects a net loss of 1 billion to 1.3 billion yuan for 2025, with a reduction in losses compared to the previous year [47]

证券代码：301487 证券简称：盟固利 公告编号：2026-006 天津国安盟固利新材料科技股份有限公司 关于天津证监局对公司采取责令改正行政监管措施整改报告的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 天津国安盟固利新材料科技股份有限公司（以下简称"公司"）于 2025 年 12 月 31 日收到中国证券监督管理委员会天津监管局（以下简称"天津证监 局"）下发的（〔2025〕44 号）《天津证监局关于对天津国安盟固利新材料科 技股份有限公司采取责令改正并对钱建林、朱武、周国水采取监管谈话措施的 决定》（以下简称"《决定书》"）。公司董事会及管理层对此高度重视，诚 恳接受天津证监局的行政监管措施，并深刻反思。收到《决定书》后，公司立 即组织董事、高级管理人员及相关责任部门进行了专题学习，深入剖析问题根 源，并制定了整改方案。现将整改情况公告如下： 一、存在问题 《决定书》原文：公司 2023 年三季度、2023 年年报、2024 年年报、2025 年一季报存在会计差错，其中，公司 2023 年三季报、年报收入均多计 4,380.53 万元，净利润均 ...

Core Viewpoint - The company, Mengguli (301487), is taking regulatory feedback seriously and is actively working on financial data verification and correction [1] Group 1: Regulatory Response - The company is organizing relevant departments and intermediaries to expedite the verification and correction of financial data [1] - The company emphasizes the importance of understanding laws, regulations, and regulatory policies to prevent future violations [1] Group 2: Internal Controls - The company is committed to strengthening financial management and internal controls to avoid recurrence of such issues [1] - The specific disclosure timeline will be based on announcements made by the company in designated information disclosure media [1]